Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death

Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death

End-stage kidney disease (ESKD) patients are at high risk of severe COVID-19. We measured 436 circulating proteins in serial blood samples from hospitalised and non-hospitalised ESKD patients with COVID-19 (n = 256 samples from 55 patients). Comparison to 51 non-infected patients revealed 221 differ...

Full description

Bibliographic Details
Main Authors: Jack Gisby, Candice L Clarke, Nicholas Medjeral-Thomas, Talat H Malik, Artemis Papadaki, Paige M Mortimer, Norzawani B Buang, Shanice Lewis, Marie Pereira, Frederic Toulza, Ester Fagnano, Marie-Anne Mawhin, Emma E Dutton, Lunnathaya Tapeng, Arianne C Richard, Paul DW Kirk, Jacques Behmoaras, Eleanor Sandhu, Stephen P McAdoo, Maria F Prendecki, Matthew C Pickering, Marina Botto, Michelle Willicombe, David C Thomas, James E Peters
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2021-03-01
Series:eLife
Subjects:
COVID-19
proteomics
longitudinal
biomarkers
cytokines
end-stage kidney disease
Online Access:https://elifesciences.org/articles/64827

Internet

https://elifesciences.org/articles/64827

Similar Items